Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 0 | ||||
Sells | 13 | -88.3K | 100% | $5.99 | -$529K |
Net | -13 | -88.3K | -100% | -$529K |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Matthew C. Kapusta | CEO, Managing Director, Director | $8.8M | -$203K | -2.26% | Dec 10, 2024 |
Christian Klemt | Chief Financial Officer | $1.26M | -$123K | -8.89% | Dec 8, 2024 |
Ricardo Dolmetsch | President, R&D | $1.22M | Sep 18, 2023 | ||
Alexander Edward Kuta III | Executive VP, Operations | $674K | Mar 7, 2023 | ||
Pierre Caloz | Chief Operating Officer | $557K | -$75.3K | -11.9% | Jun 17, 2024 |
Walid Abi-Saab | Chief Medical Officer | $503K | -$6.31K | -1.24% | Jun 26, 2024 |
Jeannette Potts | Chief Legal Officer | $457K | -$23.8K | -4.95% | Jun 13, 2024 |
Robert Gut | Director | $251K | -$17.9K | -6.66% | Jun 19, 2024 |
Madhavan Balachandran | Director | $153K | -$11.4K | -6.94% | Jun 19, 2024 |
Jeremy P. Springhorn | Director | $153K | -$11.4K | -6.94% | Jun 19, 2024 |
David D. Meek | Director | $136K | -$11.4K | -7.73% | Jun 19, 2024 |
Leonard Post | Director | $116K | -$11.4K | -8.98% | Jun 19, 2024 |
Rachelle Suzanne Jacques | Director | $108K | -$11.4K | -9.55% | Jun 19, 2024 |
Paula Soteropoulos | Director | $104K | -$11.4K | -9.9% | Jun 13, 2024 |
Jack Kaye | Director | $70.1K | -$11.4K | -14% | Jun 19, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|